Lidocaine HCl Injection USP — Class II drug recall D-0659-2026
Ongoing recall by Asclemed USA Inc., reported 2026-07-08, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0659-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Asclemed USA Inc., Torrance, CA, United States |
| Recall initiated | 2026-06-08 |
| Classified | 2026-07-02 |
| Reported by FDA | 2026-07-08 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| NDC | 85766-0187, 85766-0187-01, 85766-0187-25 |
| Lot numbers | 031926L01, 032026A01, 052026G01, AE3102, AE5052 |
| Expiration dates | 2026-11-30, 2028-04-30 |
Product
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0659-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.